Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA

Abstract Bladder cancer (BC) is notably prevalent, particularly among men. Emerging evidence highlights that traditional Chinese medicine (TCM) has distinct anticancer properties. This study focuses on recombinant MAP30, a key active constituent of Momordica charantia extract, recognized for its ant...

Full description

Saved in:
Bibliographic Details
Main Authors: Kun Lu, Liu Chao, Jin Wang, Xiangyu Wang, Longjun Cai, Jianjun Zhang, Shaoqi Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-14977-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333180718383104
author Kun Lu
Liu Chao
Jin Wang
Xiangyu Wang
Longjun Cai
Jianjun Zhang
Shaoqi Zhang
author_facet Kun Lu
Liu Chao
Jin Wang
Xiangyu Wang
Longjun Cai
Jianjun Zhang
Shaoqi Zhang
author_sort Kun Lu
collection DOAJ
description Abstract Bladder cancer (BC) is notably prevalent, particularly among men. Emerging evidence highlights that traditional Chinese medicine (TCM) has distinct anticancer properties. This study focuses on recombinant MAP30, a key active constituent of Momordica charantia extract, recognized for its antiviral, immunomodulatory, and antitumor effects. We discovered that MAP30 suppresses BC cell proliferation and induces apoptosis in a dose-responsive manner. It also hinders cell migration, as evidenced by Transwell and wound healing assays. In nude mice, MAP30 injections adjacent to tumors significantly curtail tumor growth. Molecular analyses after MAP30 exposure show elevated SA-β-Gal activity and increased expression of cell cycle inhibitors p21 and p16 in BC cells. Integrating TCGA BC data, MAP30 appears to correct dysregulated gene expression associated with the cell cycle, senescence, apoptosis, and key pathways such as FOXO, TNF, and MAPK. Proteomic analysis identifies CENPA as a central molecule inhibited by MAP30. Correlation studies reveal CENPA’s significant association with oncogenic and immune-modulatory gene expression and immune cell infiltration. CENPA knockdown diminishes BC cell growth and motility, while its overexpression in MAP30-treated cells reverses these effects, suggesting CENPA’s pivotal role in MAP30’s anticancer activity and its potential as a therapeutic target. In conclusion, recombinant MAP30 effectively hampers bladder cancer cell proliferation and migration via CENPA downregulation and induces apoptosis and senescence, offering therapeutic potential against bladder cancer.
format Article
id doaj-art-63ca15353c6f4a7caabbea784944c7cc
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-63ca15353c6f4a7caabbea784944c7cc2025-08-20T03:45:57ZengNature PortfolioScientific Reports2045-23222025-08-0115111410.1038/s41598-025-14977-ySuppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPAKun Lu0Liu Chao1Jin Wang2Xiangyu Wang3Longjun Cai4Jianjun Zhang5Shaoqi Zhang6Department of Oncology, Suqian Hospital of Nanjing Drum Tower Hospital Group, The Affiliated Suqian Hospital of Xuzhou Medical UniversityDepartment of Urology, Suqian Hospital of Nanjing Drum Tower Hospital Group, The Affiliated Suqian Hospital of Xuzhou Medical UniversitySuzhou Medical College of Soochow UniversityDepartment of Urology, Suqian Hospital of Nanjing Drum Tower Hospital Group, The Affiliated Suqian Hospital of Xuzhou Medical UniversityDepartment of Urology, Suqian Hospital of Nanjing Drum Tower Hospital Group, The Affiliated Suqian Hospital of Xuzhou Medical UniversityDepartment of Urology, Suqian Hospital of Nanjing Drum Tower Hospital Group, The Affiliated Suqian Hospital of Xuzhou Medical UniversityDepartment of Urology, Suqian Hospital of Nanjing Drum Tower Hospital Group, The Affiliated Suqian Hospital of Xuzhou Medical UniversityAbstract Bladder cancer (BC) is notably prevalent, particularly among men. Emerging evidence highlights that traditional Chinese medicine (TCM) has distinct anticancer properties. This study focuses on recombinant MAP30, a key active constituent of Momordica charantia extract, recognized for its antiviral, immunomodulatory, and antitumor effects. We discovered that MAP30 suppresses BC cell proliferation and induces apoptosis in a dose-responsive manner. It also hinders cell migration, as evidenced by Transwell and wound healing assays. In nude mice, MAP30 injections adjacent to tumors significantly curtail tumor growth. Molecular analyses after MAP30 exposure show elevated SA-β-Gal activity and increased expression of cell cycle inhibitors p21 and p16 in BC cells. Integrating TCGA BC data, MAP30 appears to correct dysregulated gene expression associated with the cell cycle, senescence, apoptosis, and key pathways such as FOXO, TNF, and MAPK. Proteomic analysis identifies CENPA as a central molecule inhibited by MAP30. Correlation studies reveal CENPA’s significant association with oncogenic and immune-modulatory gene expression and immune cell infiltration. CENPA knockdown diminishes BC cell growth and motility, while its overexpression in MAP30-treated cells reverses these effects, suggesting CENPA’s pivotal role in MAP30’s anticancer activity and its potential as a therapeutic target. In conclusion, recombinant MAP30 effectively hampers bladder cancer cell proliferation and migration via CENPA downregulation and induces apoptosis and senescence, offering therapeutic potential against bladder cancer.https://doi.org/10.1038/s41598-025-14977-yMomordica charantiaMAP30Cell senescenceCENPATraditional Chinese medicine
spellingShingle Kun Lu
Liu Chao
Jin Wang
Xiangyu Wang
Longjun Cai
Jianjun Zhang
Shaoqi Zhang
Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
Scientific Reports
Momordica charantia
MAP30
Cell senescence
CENPA
Traditional Chinese medicine
title Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
title_full Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
title_fullStr Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
title_full_unstemmed Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
title_short Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
title_sort suppressive effects of momordica charantia map30 on the senescence proliferation and migration of bladder cancer cells mediated by cenpa
topic Momordica charantia
MAP30
Cell senescence
CENPA
Traditional Chinese medicine
url https://doi.org/10.1038/s41598-025-14977-y
work_keys_str_mv AT kunlu suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa
AT liuchao suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa
AT jinwang suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa
AT xiangyuwang suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa
AT longjuncai suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa
AT jianjunzhang suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa
AT shaoqizhang suppressiveeffectsofmomordicacharantiamap30onthesenescenceproliferationandmigrationofbladdercancercellsmediatedbycenpa